These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10906161)

  • 21. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody.
    Wan Y; Gu L; Suzuki K; Karasawa T; Fujioka Y; Han GD; Koike H; Kawachi H; Shimizu F
    Nephron Exp Nephrol; 2005; 99(4):e121-9. PubMed ID: 15722645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
    Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
    Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
    Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
    Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo effect of OPC15161, a superoxide scavenger, on anti-Thy1 nephritis.
    Hamada N; Nagase M
    Eur J Pharmacol; 1996 Dec; 317(1):123-8. PubMed ID: 8982728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular actin impairs glomerular capillary repair in experimental mesangioproliferative glomerulonephritis.
    Janssen U; Eitner F; Kunter U; Ostendorf T; Wolf G; Chaponnier C; Gabbiani G; Kerjaschki D; Floege J
    Nephron Exp Nephrol; 2003; 93(4):e158-67. PubMed ID: 12759577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic mechanism of Saikosaponin-d in anti-Thy1 mAb 1-22-3-induced rat model of glomerulonephritis.
    Li P; Gong Y; Zu N; Li Y; Wang B; Shimizu F
    Nephron Exp Nephrol; 2005; 101(4):e111-8. PubMed ID: 16103731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
    Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The safety of isotretinoin in patients with lupus nephritis: a comprehensive review.
    Miziołek B; Bergler-Czop B; Stańkowska A; Brzezińska-Wcisło L
    Cutan Ocul Toxicol; 2017 Mar; 36(1):77-84. PubMed ID: 27160965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
    Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
    Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the fibroblast growth factor receptor 1-4 genes in glomeruli in anti-Thy1.1 mesangial proliferative glomerulonephritis.
    Jyo-Oshiro Y; Sasaki T; Kawakami Y; Nohno T; Itoh N; Osawa G; Kashihara N
    Virchows Arch; 1999 Nov; 435(5):501-8. PubMed ID: 10592054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of multi-glycoside of Tripterygium wilfordii Hook. f. on proteinuria and expression of slit diaphragm-associated molecules in rats with anti-thy1.1 glomerulonephritis].
    Wan YG; Sun W; Wang Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Dec; 26(12):1094-102. PubMed ID: 17205822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenomedullin reduces mesangial cell number and glomerular inflammation in experimental mesangioproliferative glomerulonephritis.
    Plank C; Hartner A; Klanke B; Geissler B; Porst M; Amann K; Hilgers KF; Rascher W; Dötsch J
    Kidney Int; 2005 Sep; 68(3):1086-95. PubMed ID: 16105039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of capillary repair in proliferative glomerulonephritis results in persistent glomerular inflammation with glomerular sclerosis.
    Masuda Y; Shimizu A; Kataoka M; Arai T; Ishikawa A; Du X; Saito SK; Aki K; Nagasaka S; Mii A; Fujita E; Fukuda Y
    Lab Invest; 2010 Oct; 90(10):1468-81. PubMed ID: 20644521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The novel NF-kappaB activation inhibitor dehydroxymethyl-epoxyquinomicin suppresses anti-Thy1.1-induced glomerulonephritis in rats.
    Kosaka T; Miyajima A; Kikuchi E; Horiguchi Y; Umezawa K; Ohigashi T; Nakashima J; Asano T; Oya M
    Nephron Exp Nephrol; 2008; 110(1):e17-24. PubMed ID: 18685260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
    Villa L; Boor P; Konieczny A; Kunter U; van Roeyen CR; Denecke B; Gan L; Neusser MA; Cohen CD; ; Eitner F; Scholl T; Ostendorf T; Floege J
    J Pathol; 2013 Apr; 229(5):672-84. PubMed ID: 23192593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single application of low-dose mycophenolate mofetil-OX7-immunoliposomes ameliorates experimental mesangial proliferative glomerulonephritis.
    Suana AJ; Tuffin G; Frey BM; Knudsen L; Mühlfeld C; Rödder S; Marti HP
    J Pharmacol Exp Ther; 2011 May; 337(2):411-22. PubMed ID: 21349934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized rats.
    Morath C; Ratzlaff K; Dechow C; Schwenger V; Schaier M; Zeier B; Peters J; Tsukada M; Zouboulis CC; Waldherr R; Gross ML; Ritz E; Zeier M; Wagner J
    J Mol Med (Berl); 2009 Jan; 87(1):53-64. PubMed ID: 18795249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats.
    Chen YM; Hu-Tsai MI; Lin SL; Tsai TJ; Hsieh BS
    Nephrol Dial Transplant; 2003 Dec; 18(12):2505-14. PubMed ID: 14605272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of TJN-331 on anti-Thy1 nephritis in rats via inhibition of transforming growth factor-β1 production.
    Saegusa Y; Sadakane C; Koseki J; Hasegawa Y; Shindo S; Maruyama H; Kase Y; Takeda S; Takeda H; Hattori T
    Biol Pharm Bull; 2010; 33(10):1710-5. PubMed ID: 20930380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of all-trans-retinoic acid (atRA) on inducible nitric oxide synthase (iNOS) activity and transforming growth factor beta-1 production in experimental anti-GBM antibody-mediated glomerulonephritis.
    Datta PK; Reddy RS; Lianos EA
    Inflammation; 2001 Dec; 25(6):351-9. PubMed ID: 11831438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.